Research progress of the prognosis of diffuse large B-cell lymphoma：reports from the 57th American Society of Hematology annual meeting
10.3760/cma.j.issn.1009-9921.2016.02.002
- VernacularTitle:弥漫大B细胞淋巴瘤预后研究进展：第57届美国血液学会年会报道
- Author:
Xinyu ZHANG
;
Wei XU
;
Jianyong LI
- Publication Type:Journal Article
- Keywords:
Lymphoma,large B-cell,diffuse;
Prognosis;
American Society of Hematology annual meeting
- From:
Journal of Leukemia & Lymphoma
2016;25(2):69-71,74
- CountryChina
- Language:Chinese
-
Abstract:
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma with highly heterogeneous clinical course. How to recognize patients with high risk is coming into the focus of the 57th American Society of Hematology (ASH) annual meeting. The International Prognostic Index (IPI) score as a classic prognostic system is challenged by variety of new prognosis systems. The tumor microenvironment plays an important role in progression of lymphoma, and its prognostic value draw much more attention. The value of PET-CT for prognosis of DLBCL has also been affirmed in this meeting.
